Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Pentaxim

Snippet

Sponsor: Sanofi | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED